Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia

References

• Lee J T, McCubrey J A. The Raf/MEK/ERK signal transduction cascade as target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486–507
   PubMed Web of Science ®Google Scholar
• Burnett A K. Introduction: modern management of acute myeloid leukemia. Semin Hematol 2001; 38: 1–2
   PubMed Web of Science ®Google Scholar
• Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetic on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322–2333
   PubMed Web of Science ®Google Scholar
• Winton E F, Langston A A. Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults. Semin Oncol 2004; 2: 80–86
   Web of Science ®Google Scholar
• Tallman S, Kwaan H C. Intravascular clotting activation and bleeding in patients with hematologic malignancies. Rev Clin Exp Hematol 2004; 8(1)E1
   PubMedGoogle Scholar
• Lopez-Pedrera Ch, Jardí M, Malagón M M, Inglés-Esteve J, Dorado G, Torres A, et al. Tissue factor (TF) and urokinase plasminogen activator receptor (uPAR) and bleeding complications in leukemic patients. Thromb Haemost 1997; 77: 62–70
   PubMed Web of Science ®Google Scholar
• Velasco F, López-Pedrera Ch, Borrell M, Fontcuberta J, Borell M, Torres A. Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation. Blood Coagul Fibrinol 1997; 8: 70–72
   PubMed Web of Science ®Google Scholar
• Nadir Y, Katz T, Sarig G, Hoffman R, Oliven A, Rowe J M, et al. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. Haematologica 2005; 90(11)1549–1556
   PubMed Web of Science ®Google Scholar
• Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 2006; 32: 54–70
   PubMed Web of Science ®Google Scholar
• Versteeg H H, Spek C A, Peppelenbosch M P, Richel D J. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 2004; 10: 6–11
   PubMed Web of Science ®Google Scholar
• Chen J, Bierhaus A, Schiekofer S, Andrassy M, Chem B, Stern D M, et al. Tissue factor: a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001; 86: 334–345
   PubMed Web of Science ®Google Scholar
• Sampson M T, Kakkar A K. Coagulation proteases and human cancer. Biochem Soc Trans 2002; 30: 201–207
   PubMed Web of Science ®Google Scholar
• Belting M, Dorrel M I, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10: 502–509
   PubMed Web of Science ®Google Scholar
• Ruf W, Mueller B M. Tissue factor signaling. Thromb Haemost 1999; 82: 175–182
   PubMed Web of Science ®Google Scholar
• Towatari M, Lida H, Tanimoto M, Iwata H, Hamaguchi M, Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 1997; 11: 479–484
   PubMed Web of Science ®Google Scholar
• Versteeg H H, Pappeleubosch M P, Spek C A. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signaling?. Thromb Haemost 2001; 86: 1353–1359
   PubMed Web of Science ®Google Scholar
• Bellamy W T. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol 2001; 28: 551–559
   PubMed Web of Science ®Google Scholar
• Padro T, Bieker R, Ruiz S, Steins M, Retzlaff S, Burger H, et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 2002; 16(7)1302–1310
   PubMed Web of Science ®Google Scholar
• Rak J, Yu J L, Klement G, Kerbel R S. Oncogenes and angiogenesis: signaling three-dimensional tumor growth?. J Investig Dermatol Symp Proc 2000; 5: 24–33
   PubMed Web of Science ®Google Scholar
• Birkenkamp K U, Geugien M, Schepers H, Westra J, Lemmink H H, Vellenga E. Constitutive NF-κB DNA-binding activity in AMLs is frequently mediated by Ras/PI3K/PKB-dependent pathway. Leukemia 2004; 18: 103–112
   PubMed Web of Science ®Google Scholar
• Andrews N C, Faller D V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499
   PubMed Web of Science ®Google Scholar
• Schreiber E, Mathias P, Muller M M, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small umber of cells. Nucleic Acids Res 1989; 17: 6419
   PubMed Web of Science ®Google Scholar
• Zwacka R M, Zhang Y, Zhou W, Halldorson J, Engelhardt J F. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 1998; 28: 1022–1030
   PubMed Web of Science ®Google Scholar
• Ghannadan M, Wimazal F, Simonitsch I, Sperr W R, Mayerhofer M, Sillaber C, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Am J Clin 2003; 119(5)663–671
   Web of Science ®Google Scholar
• Hussong J W, Rodgers G M, Shami P J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313
   PubMed Web of Science ®Google Scholar
• Dias S, Shmelkov S V, Lam G, Rafii S. VEGF(165) promotes survival of leukemic cells by Hsp-90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 2002; 99: 2532–2540
   PubMed Web of Science ®Google Scholar
• Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, Martin R, Binder B R, et al. Specificity, diversity and convergence in VEGF and TNFα signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J 2001; 15: 230–242
   PubMed Web of Science ®Google Scholar
• Hall A J, Vos H L, Bertina R M. Lipopolysaccharide induction of tissue factor in THP-1 involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation. J Biol Chem 1999; 274: 376–383
   PubMed Web of Science ®Google Scholar
• Oeth P, Parry G C, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NFkappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365–374
   PubMed Web of Science ®Google Scholar
• Huang S, Robinson J B, Deguzman A, Bucana C D, Fidler I J. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 2000; 60: 5334–5339
   PubMed Web of Science ®Google Scholar
• Lu T, Sathe S S, Swiatkowski S M, Hampole C V, Stark G R. Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer. Oncogene 2004; 23: 2138–2145
   PubMed Web of Science ®Google Scholar